Many people taking Wegovy (semaglutide) for weight management wonder whether they can still enjoy occasional treats like ice cream
Its important to approach GLP-1 therapy judiciously, when its clinically appropriate, with the intent to eventually transition people away from perpetual dependence on these medications through lifestyle interventions such as healthy eating and physical activity
Until larger human trials are available, most clinicians recommend empty-stomach administration for both oral and sublingual routes
Description Research Overview Retatrutide is a synthetic multi-receptor investigational peptide studied for coordinated signalling across the GLP-1, GIP, and glucagon receptor systems
Some people start noticing appetite suppression within the first 1 to 4 weeks, even at the starting dose of 0.25mg
These are typically most noticeable in the first few weeks or right after a dose change, and can include nausea, diarrhea, constipation, fatigue, and abdominal pain